Quick Answer
LEXICON PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $34.33 million for the year ending 2025.
- LEXICON PHARMACEUTICALS, INC. showed a decrease of -48.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from LEXICON PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), LEXICON PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 27.3%.
- Historical annual values: Fiscal year 2025: $34.33 million | Fiscal year 2024: $66.66 million | Fiscal year 2023: $22.47 million | Fiscal year 2022: $46.35 million | Fiscal year 2021: $64.07 million | Fiscal year 2020: $126.26 million | Fiscal year 2019: $36.11 million | Fiscal year 2018: $80.39 million | Fiscal year 2017: $61.66 million | Fiscal year 2016: $46.60 million | Fiscal year 2015: $202.99 million | Fiscal year 2014: $137.27 million | Fiscal year 2013: $37.50 million | Fiscal year 2012: $30.42 million | Fiscal year 2011: $186.31 million | Fiscal year 2010: $47.21 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: